跳转至内容
Merck
CN

13-1790

Hydrogen chloride solution

0.1 M in ethanol

别名:

氯化氢乙醇溶液

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
HCl · CH3CH2OH
化学文摘社编号:
分子量:
36.46
UNSPSC Code:
41115710
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
1098214
Concentration:
0.1 M in ethanol, 1/10 N in ethanol
Form:
liquid
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

氯化氢 – 乙醇 溶液, 0.1 M in ethanol

form

liquid

availability

available only in Japan

concentration

0.1 M in ethanol, 1/10 N in ethanol

density

0.79 g/cm3 at 20 °C

SMILES string

Cl

InChI

1S/ClH/h1H

InChI key

VEXZGXHMUGYJMC-UHFFFAOYSA-N



Still not finding the right product?

Explore all of our products under 氯化氢 – 乙醇 溶液


pictograms

FlameCorrosion

signalword

Danger

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 2 - Met. Corr. 1

存储类别

3 - Flammable liquids

wgk

WGK 1

flash_point_f

55.4 °F

flash_point_c

13 °C

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Douglas M McMillan et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(7), 1804-1812 (2015-01-30)
CYP2D metabolically activates codeine to morphine, which is required for codeine analgesia. Permeability across the blood-brain barrier, and active efflux, suggests that initial morphine in the brain after codeine is due to brain CYP2D metabolism. Human CYP2D is higher in
Marta Kolodziejczak et al.
ACS chemical neuroscience, 6(7), 1219-1230 (2015-04-11)
Maturation of functional neuronal circuits during central nervous system development relies on sophisticated mechanisms. First, axonal and dendritic growth should reach appropriate targets for correct synapse elaboration. Second, pruning and neuronal death are required to eliminate redundant or inappropriate neuronal
Jay G Hosking et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(4), 1005-1015 (2014-10-21)
Successful decision making often requires weighing a given option's costs against its associated benefits, an ability that appears perturbed in virtually every severe mental illness. Animal models of such cost/benefit decision making overwhelmingly implicate mesolimbic dopamine in our willingness to